4-methoxyamphetamine has been researched along with Purpura, Thrombotic Thrombocytopenic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Azoulay, E; Bigé, N; Calvet, L; Canet, E; Chevret, S; Duceau, B; Faguer, S; Grangé, S; Joly-Laffargue, B; Klouche, K; Mariotte, E; Mayaux, J; Pène, F; Perez, P; Pichereau, C; Poulain, C; Rafat, C; Veyradier, A; Walter-Petrich, A; Zafrani, L | 1 |
Adrie, C; Azoulay, E; Boulanger, E; Bussel, A; Coppo, P; Devaux, E; Eschwège, V; Galicier, L; Gallien, S; Korach, JM; Malak, S; Malot, S; Mariotte, E; Meynard, JL; Millot, GA; Rondeau, E; Schlemmer, B; Veyradier, A; Wolf, M | 1 |
REISFIELD, DR | 1 |
1 trial(s) available for 4-methoxyamphetamine and Purpura, Thrombotic Thrombocytopenic
Article | Year |
---|---|
Magnesium sulphate in patients with thrombotic thrombocytopenic purpura (MAGMAT): a randomised, double-blind, superiority trial.
Topics: Adult; Death; Double-Blind Method; Female; Humans; Magnesium Sulfate; Male; Platelet Count; Purpura, Thrombotic Thrombocytopenic; Treatment Outcome | 2023 |
2 other study(ies) available for 4-methoxyamphetamine and Purpura, Thrombotic Thrombocytopenic
Article | Year |
---|---|
Human immunodeficiency virus-associated thrombotic microangiopathies: clinical characteristics and outcome according to ADAMTS13 activity.
Topics: Acquired Immunodeficiency Syndrome; ADAM Proteins; ADAMTS13 Protein; Adult; Case-Control Studies; CD4 Lymphocyte Count; Death; Female; France; HIV; Humans; Male; Middle Aged; Prognosis; Prospective Studies; Purpura, Thrombotic Thrombocytopenic; von Willebrand Factor | 2008 |
Death from thrombotic thrombocytopenic purpura during pregnancy.
Topics: Child; Death; Female; Humans; Infant; Pregnancy; Pregnancy Complications; Purpura; Purpura, Thrombocytopenic; Purpura, Thrombotic Thrombocytopenic; Thrombocytopenia | 1962 |